What are the differences between Teosyal (hyaluronic acid) RH4 filler and Teosyal Ultra‑Deep filler?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 7, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Teosyal RHA4 vs. Ultra-Deep: Key Differences

The provided evidence does not contain specific information comparing Teosyal RHA4 and Teosyal Ultra-Deep fillers, as the FDA drug label excerpts 1 appear to be mislabeled and describe an acne face wash rather than dermal filler specifications.

What We Know About RHA4 from Available Evidence

RHA4 Characteristics and Clinical Applications

RHA4 is a volumizing hyaluronic acid filler specifically designed for tissue support in dynamic facial areas, with excellent biocompatibility and unique biomechanical properties 2. The key distinguishing features include:

Rheological Properties

  • RHA (Resilient Hyaluronic Acid) technology is engineered to adapt to facial dynamics and movement
  • RHA4 demonstrates the ability to lift tissue efficiently in both deep and superficial fat compartments 2
  • Preserves adipose tissue biomechanics while providing structural support 2

Clinical Performance

  • Optimal for multilayering technique: RHA4 can be injected in both deep and superficial midface fat compartments without compromising facial expressiveness 2
  • Demonstrates excellent tissue integration with minimal local inflammation
  • Promotes rapid collagen bundle formation within the filler matrix 2
  • Allows for increased extracellular matrix presence, neovascularization, and denser collagen deposition over time 2

Biological Integration

  • Shows superior cytocompatibility with human fibroblasts and adipose stem cells
  • Integrates gradually over time with well-tolerated tissue response
  • Does not impede fat motion biomechanics while providing visible tissue lift 2

General Principles for Filler Selection (Applicable Context)

Understanding Filler Differentiation

When comparing fillers within the same brand family, the critical parameters to consider include:

Rheological Parameters 3, 4, 5

  • Elastic modulus (G'): Higher G' products are better suited for:

    • Thicker skin
    • Deeper injection planes
    • Areas requiring more structural support
  • Lower G' products are preferable for:

    • More superficial planes
    • Thinner, more delicate skin
    • Areas requiring natural movement

Hyaluronic Acid Concentration

  • Concentration affects swelling factor and cohesion, but only when comparing products with the same crosslinking technology 3
  • Higher HA concentrations generally correlate with greater volumizing capacity

Crosslinking Technology

  • The type and degree of crosslinking significantly influences:
    • Product longevity
    • Tissue integration
    • Resistance to degradation
    • Injectability characteristics 6

Clinical Decision-Making Framework

For Deep Volume Restoration

  • Products with higher G' values (like those described for body contouring applications) show greater elasticity and stiffness 7
  • Suitable for high-load applications requiring sustained structural support

For Dynamic Facial Areas

  • RHA technology specifically addresses areas with significant movement
  • Maintains natural facial expressiveness while providing correction 2

Injection Depth Considerations

  • Deep plane injections: Require fillers with higher structural integrity
  • Superficial injections: Need products that integrate smoothly without creating visible irregularities

Critical Caveats

Product-Specific Expertise Required

Each HA-based dermal filler requires specific expertise for optimal injection due to differing viscoelastic characteristics and injectability attributes 6. The injectability varies significantly based on:

  • Polymer concentration
  • Crosslinking type and degree
  • Presence of lidocaine
  • Needle gauge size 6

Avoid Common Pitfalls

  • Do not assume equivalent performance between products based solely on HA concentration
  • Rheological properties can vary widely even within the same brand family 3, 4
  • Always account for the specific anatomical location and mechanical demands of the treatment area

What's Missing from the Evidence

The provided evidence lacks:

  • Specific FDA labeling for Teosyal Ultra-Deep filler
  • Direct comparative studies between RHA4 and Ultra-Deep
  • Manufacturer specifications for Ultra-Deep's rheological properties
  • Clinical outcome comparisons between these two specific products

To obtain accurate comparative information, consult the manufacturer's technical specifications for both products, focusing on G' values, HA concentration, crosslinking density, and recommended injection depths.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.